Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
HFA 23: IRONMAN: Reasons for Hospitalisation and Biomarkers
Author(s): John GF Cleland Added: 11 months ago
ESC-HFA 23 - Prof John Cleland (University of Glasgow, UK) joins us onsite to discuss the IRONMAN trial (NCT02642562). IRONMAN was a randomised, open-label multicenter trial, which aimed to assess the effectiveness of intravenous iron in patients with heart failure and iron deficiency as compared to standard care. It demonstrated that the administration of IV FDI was associated with lower rates… View more

Heart Failure
Author(s): Shanmugam Uthamalingam , James L Januzzi Added: 3 years ago
Several cardiac biomarkers may aid in the diagnostic and prognostic evaluation of acute and chronic heart failure. In this article we discuss more novel and emerging applications of such established cardiac biomarkers in heart failure and review emerging data for several other promising markers. Novel Applications of Established Cardiac Biomarkers—Natriuretic Peptides B-type natriuretic peptide… View more

Heart Failure

MI/ACS
Author(s): Wolfgang Koenig , Natalie Khuseyinova Added: 3 years ago
Atherosclerosis is characterized by a non-specific local inflammatory process accompanied by a systemic response. A number of prospective studies in initially healthy subjects and in patients with manifest atherosclerosis have now convincingly demonstrated a strong and independent association between even slightly elevated concentrations of various systemic markers of inflammation and a number of… View more

Prevention & Chronic Conditions

MI/ACS
Author(s): Wolfgang Koenig , Natalie Khuseyinova Added: 3 years ago
Atherosclerosis is characterized by a non-specific local inflammatory process accompanied by a systemic response. A number of prospective studies in initially healthy subjects and in patients with manifest atherosclerosis have now convincingly demonstrated a strong and independent association between even slightly elevated concentrations of various systemic markers of inflammation and a number of… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
Author(s): James De Lemos Added: 3 years ago
Acute coronary syndromes (ACS) is an umbrella term comprising a spectrum of clinical conditions ranging from unstable angina to non-ST elevation myocardial infarction and ST elevation myocardial infarction. ACS begins when an atherosclerotic plaque ruptures or erodes and a platelet-fibrin clot obstructs coronary blood flow. These critical disorders are a major cause of emergency medical care and… View more

Imaging & Diagnostics

MI/ACS
Impact of Left Ventricular Ejection Fraction on the Correlation between Congestion Biomarkers and Blood Volume Measurements in Heart Failure
Author(s): Veraprapas Kittipibul , Marat Fudim Added: 4 months ago
Christie Ballantyne
Job title: Chief of Cardiovascular Research and Director of the Center for Cardiometabolic Disease Prevention
Dr Christie Ballantyne is the Chief of Cardiovascular Research,Director of the Center for Cardiometabolic Disease Prevention, and Professor of Medicine atBaylor College of Medicine in Texas, US. He received his MD from Baylor College of Medicine and performed both his internal medicine residency at The University of Texas Southwestern Medical School. He completed a cardiology fellowship at… View more
Job title: Professor of Medicine
Dr Eileen O’Meara is Professor at the Department of Medicine at the University of Montrealand practices cardiology at the Montreal Heart Institute. Dr O’Meara pursued a Fellowship in Heart Failure at the Western Infirmary & Glasgow Royal Infirmary in the UK, and another in Stress Echocardiography and Tissue Doppler at Hôpital Européen Georges Pompidou in Paris. Her research focuses on… View more
ACC 2021: Findings From the RESCUE Trial
Author(s): Paul M Ridker Added: 2 years ago
In this video, Dr Paul Ridker (Brigham and Women’s Hospital, Boston, MA, US) discusses the findings from the RESCUE trial, which aimed to assess whether Ziltivekimab is effective in reducing cardiovascular biomarkers in high-risk patients with chronic kidney disease. Dr Ridker also outlines the upcoming ZEUS outcomes study following the results of this trial. Questions: 1. What does this trial… View more

Prevention & Chronic Conditions

CV Disease in Special Populations
Valentina Puntmann
Dr Valentina Puntmann is Deputy Head of Department and senior clinical investigator with subspecialty interest in mutimodality cardiovascular imaging and conduct of clinical trials using imaging biomarkers. Her research projects focus on the development of novel imaging biomarkers for the detection of cardiovascular injury, supporting risk stratification, prevention and therapy. She is chief… View more